Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?
Authors
Keywords
Phase I clinical investigation, Clinical trials, Drug regulation, Medical ethics, Peer review, Phase II clinical investigation, Safety studies, Animal models
Journal
PLOS BIOLOGY
Volume 16, Issue 4, Pages e2004879
Publisher
Public Library of Science (PLoS)
Online
2018-04-06
DOI
10.1371/journal.pbio.2004879
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consider drug efficacy before first-in-human trials
- (2017) Jonathan Kimmelman et al. NATURE
- No publication without confirmation
- (2017) Jeffrey S. Mogil et al. NATURE
- Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review
- (2017) James Mattina et al. PLOS BIOLOGY
- Animal Study Registries: Results from a Stakeholder Analysis on Potential Strengths, Weaknesses, Facilitators, and Barriers
- (2016) Susanne Wieschowski et al. PLOS BIOLOGY
- Where Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and Stroke
- (2016) Constance Holman et al. PLOS BIOLOGY
- Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor
- (2016) Lucile Vogt et al. PLOS BIOLOGY
- Assessing risk/benefit for trials using preclinical evidence: a proposal
- (2015) Jonathan Kimmelman et al. JOURNAL OF MEDICAL ETHICS
- Risk of Bias in Reports of In Vivo Research: A Focus for Improvement
- (2015) Malcolm R. Macleod et al. PLOS BIOLOGY
- Why clinical translation cannot succeed without failure
- (2015) Alex John London et al. eLife
- Distinguishing between Exploratory and Confirmatory Preclinical Research Will Improve Translation
- (2014) Jonathan Kimmelman et al. PLOS BIOLOGY
- Meta-analysis of data from animal studies: A practical guide
- (2013) H.M. Vesterinen et al. JOURNAL OF NEUROSCIENCE METHODS
- Bringing rigour to translational medicine
- (2013) David W. Howells et al. Nature Reviews Neurology
- Threats to Validity in the Design and Conduct of Preclinical Efficacy Studies: A Systematic Review of Guidelines for In Vivo Animal Experiments
- (2013) Valerie C. Henderson et al. PLOS MEDICINE
- Raise standards for preclinical cancer research
- (2012) C. Glenn Begley et al. NATURE
- Should preclinical studies be registered?
- (2012) Jonathan Kimmelman et al. NATURE BIOTECHNOLOGY
- Publication Bias in Laboratory Animal Research: A Survey on Magnitude, Drivers, Consequences and Potential Solutions
- (2012) Gerben ter Riet et al. PLoS One
- A theoretical framework for early human studies: uncertainty, intervention ensembles, and boundaries
- (2012) Jonathan Kimmelman Trials
- Believe it or not: how much can we rely on published data on potential drug targets?
- (2011) Florian Prinz et al. NATURE REVIEWS DRUG DISCOVERY
- Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
- (2010) Emily S. Sena et al. PLOS BIOLOGY
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals
- (2009) Carol Kilkenny et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search